Moscow Will Conclude 2nd Offset Contract

01 October 2018


Moscow will conclude with OOO R-Opra the second offset drug supply contract with supplier’s counter investment obligations to create or to upgrade and/or to launch a drug production facility in the city.

R-Opra offered to fulfill the contract for RUR 18.4 bn at the starting maximum contract price of RUR 22.5 bn.  

Over half of the drugs to be manufactured within the offset contract are not being produced in Russia.